Population Pharmacokinetics and Dose–Exposure Proportionality of Edoxaban in Healthy Volunteers

Background and Objectives Edoxaban is a novel direct inhibitor of activated factor Xa. A previous human pharmacokinetic study suggested a less than proportional increase in edoxaban exposure at higher dose concentrations, but the quantitative relationship, including the point of inflection, has not...

Ausführliche Beschreibung